Research output per year
Research output per year
Personal profile
Further information
Branches of science
- 301 Medical-Theoretical Sciences, Pharmacy
Fingerprint
Dive into the research topics where Alyssa Schnabl is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Most recent collaborations and top research areas
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Targeting pyruvate kinase M2 (PKM2) reduces T cell pathogenicity in multiple sclerosis.
Ellmeier, E. (First author), Schnabl, A., Meissel, J., Stracke, A., Rittchen, S., Passegger, C., Tafrali, C., Demjaha, R., Martinez Serrat, M., Kaiser, T., Zeiler, L., Seifried, K., Topler, A., Heschl, B., Damulina, A., Runtsch, M., Fessler, J., Hofer, E., Khalil, M. & Angiari, S., Jun 2026, In: eBioMedicine. 128, p. 106314 21 p., 106314.Research output: Contribution to journal › Research article
-
Targeting pyruvate kinase M2 (PKM2) reduces T cell pathogenicity in multiple sclerosis
Ellmeier, E., Schnabl, A., Meissel, J., Stracke, A., Rittchen, S., Stoeger, L., Tafrali, C., Demjaha, R., Martinez-Serrat, M., Kaiser, T., Zeiler, L.-C., Seifried, K., Topler, A., Klemen, I., Heschl, B., Damulina, A., Runtsch, M. C., Fessler, J., Hofer, E. & Khalil, M. & 1 others, , Sept 2025, In: Multiple Sclerosis Journal. 31, 3, p. 971-971 1 p.Research output: Contribution to journal › Conference abstract
-
Coenzyme A fueling with pantethine limits autoreactive T cell pathogenicity in experimental neuroinflammation
Ellmeier, E., Carlucci, T., Budui, S., Bach, S., Dusi, S., Meissel, J., Schnabl, A., Tafrali, C., Demjaha, R., Khalil, M., Bordag, N., Angelini, G., Terrabuio, E., Zenaro, E., Laudanna, C., Rossi, B., Constantin, G. & Angiari, S., Sept 2024, In: European Journal of Immunology. 54, p. 401-401 1 p.Research output: Contribution to journal › Conference abstract
-
Coenzyme A fueling with pantethine limits autoreactive T cell pathogenicity in experimental neuroinflammation.
Angiari, S. (First author), Carlucci, T., Budui, S., Bach, S., Dusi, S., Meissel, J., Ellmeier, E., Schnabl, A., Stracke, A., Bordag, N., Tafrali, C., Demjaha, R., Khalil, M., Angelini, G., Terrabuio, E., Pietronigro, E., Zenaro, E., Laudanna, C., Rossi, B. & Constantin, G., 5 Nov 2024, In: Journal of Neuroinflammation. 21, 1, p. 287 20 p., 287.Research output: Contribution to journal › Research article
6 Citations (Web of Science) -
Targeting pyruvate kinase M2 to limit T cell pathogenicity in multiple sclerosis
Schnabl, A., Ellmeier, E., Stracke, A., Seifried, K., Tafrali, C., Demjaha, R., Wurth, S., Khalil, M. & Angiari, S., Sept 2024, In: European Journal of Immunology. 54, p. 74-74 1 p.Research output: Contribution to journal › Conference abstract
Activities
- 3 Scientific talk or presentation
-
Targeting pyruvate kinase M2 to limit T cell pathogenicity in multiple sclerosis
Schnabl, A. (Author), Ellmeier, E. (Author), Stracke, A. (Author), Seifried, K. (Author), Tafrali, C. (Author), Demjaha, R. (Author), Wurth, S. (Author), Khalil, M. (Author) & Angiari, S. (Author)
2024Activity: Talk, presentation or poster › Scientific talk or presentation › On site
-
Coenzyme A fueling with pantethine limits autoreactive T cell pathogenicity in experimental neuroinflammation
Ellmeier, E. (Author), Carlucci, T. (Author), Budui, S. (Author), Bach, S. (Author), Dusi, S. (Author), Meissel, J. (Author), Schnabl, A. (Author), Tafrali, C. (Author), Demjaha, R. (Author), Khalil, M. (Author), Bordag, N. (Author), Angelini, G. (Author), Terrabuio, E. (Author), Zenaro, E. (Author), Laudanna, C. (Author), Rossi, B. (Author), Constantin, G. (Author) & Angiari, S. (Author)
2024Activity: Talk, presentation or poster › Scientific talk or presentation › On site
-
Targeting pyruvate kinase M2 to limit T cell pathogenicity in multiple sclerosis
Ellmeier, E. (Speaker), Schnabl, A. (Author), Seifried, K. (Author), Stracke, A. (Author), Tafrali, C. (Author), Demjaha, R. (Author), Khalil, M. (Author) & Angiari, S. (Author)
2023Activity: Talk, presentation or poster › Scientific talk or presentation › On site